HUTCHMED (ADR) (HCM)
Develops targeted therapies and immunotherapies, commercializing medicines in China and through global partners.
$14.22
vs last close+0.15 (+1.03%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 2.48% | 4.33M ADS | |
|---|---|---|---|
| 56 holders · as of Jun 30, 2026 | |||
| Insiders | 0.05% | 84.0K ADS | |
| 2 holders · as of Mar 11, 2026 | |||
| Other | 97.47% | 170.06M ADS | |
| remainder | |||
174.47M ADS as of Sep 5, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
13F, as of Jun 30, 2026
56 holders · 4.33M shares · 9 new positions · 23 increased · 23 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Schroder Investment Management Group | 1.48M | 0.85% | 0 | Aug 13, 2026 |
| Allianz Asset Management GmbH | 674.5K | 0.39% | −163.0K | Sep 2, 2026 |
| State Street Corp | 313.6K | 0.18% | +8.8K | Aug 7, 2026 |
| Aia Group Ltd | 291.2K | 0.17% | 0 | Aug 13, 2026 |
| M&G PLC | 242.8K | 0.14% | −12.7K | Aug 6, 2026 |
| Amundi | 204.4K | 0.12% | −27.9K | Aug 11, 2026 |
| Jane Street Group, LLC | 194.5K | 0.11% | +118.0K | Aug 14, 2026 |
| Renaissance Technologies LLC | 130.2K | 0.07% | −1.9K | Aug 13, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.